Sarker, D., Ang, J. E., Baird, R., Kristeleit, R., Shah, K., Moreno, V., . . . de Bono, J. S. (2014). First-in-human Phase I study of Pictilisib (GDC-0941), a potent pan-class I phosphatidylinositol-3-kinase (PI3K) inhibitor, in patients with advanced solid tumors. Clin Cancer Res.
Citación estilo ChicagoSarker, Debashis, et al. "First-in-human Phase I Study of Pictilisib (GDC-0941), a Potent Pan-class I Phosphatidylinositol-3-kinase (PI3K) Inhibitor, in Patients With Advanced Solid Tumors." Clin Cancer Res 2014.
Cita MLASarker, Debashis, et al. "First-in-human Phase I Study of Pictilisib (GDC-0941), a Potent Pan-class I Phosphatidylinositol-3-kinase (PI3K) Inhibitor, in Patients With Advanced Solid Tumors." Clin Cancer Res 2014.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.